Session: Plenary Lecture 2
Date: May 5th, 2020
Time: 13:40 to 14:30
Venue: 201 Meeting Room
Mien-Chie Hung, Ph.D. is the President for China Medical University in Taichung, Taiwan. He was vice president for basic research and professor and chair of the Department of Molecular and Cellular Oncology at The University of Texas MD Anderson Cancer Center. He received undergraduate and graduate degrees from the National Taiwan University and his PhD from Brandeis University. After completing postdoctoral training with Dr. Robert A. Weinberg at the Whitehead Institute/Massachusetts Institute of Technology. Dr. Hung was recruited to MD Anderson in 1986. Dr. Hung is internationally recognized for his studies of signal transduction pathways regulated by tyrosine kinase growth factor receptors, such as EGFR and HER-2/neu, as well as molecular mechanisms of tumorigenesis. Up to date, Dr. Hung has published more than 530 peer-reviewed articles, of which over 135 were published in journals with impact factor 10 or above. His lifetime h-index surpasses 115. Dr. Hung has served in many study sections of the NIH and various funding agencies in many other countries to select awardees. He is one of members of Selection Committee for Tang Prize in Biopharmaceutical Science category and 2016 Pezcoller Foundation-AACR Award. Dr. Hung also serves as an editorial member for many journals in cancer research to evaluate quality of submission. Notable, he is one of the founding Editorial Members for Cancer Cell, serves as Editor-in-chief for American Journal for Cancer Research (2015-2017) and Senior Editor for Cancer Research (American Association for Cancer Research, 2018-2021). Dr. Hung was inducted as an Academician of the Academia Sinica in Taiwan in 2002. In addition, Dr. Hung was selected as a Fellow in Biological Sciences section, American Association for the Advancement of Science (AAAS Fellow) in 2010. He served as President for the Society of Chinese Bioscientists in America (SCBA) from 2004-2005 and is also the recipient of SCBA’s Presidential Award in 2011 and Lifetime Achievement Award in 2017. In addition, Dr. Hung was awarded with The University of Texas MD Anderson Cancer Center LeMaistre Outstanding Achievement Award in 2011 as well as Faculty Achievement Award in Education (1993) and in Basic Research (1998 & 2017). In 2015, he was an awardee of the Simiao Sun Award for Biomedical Achievement, and an inaugural awardee of Breast Cancer Basic and Translational Research Outstanding Achievement Award in 2017 International Breast Cancer Stem Cell Symposium.
In 2018, he becomes the President-elect of The University of Texas Academy of Health Science Education. It is worth noting that Dr. Hung is a dedicated educator who persistently nurture next generation cancer biologists. In addition to graduating more than 55 Ph.D. students and directly supervising close to 200 postgraduate fellows, he is a recipient of prestigious educational awards including 2017 UT System Regents’ Outstanding Teaching Award and John P. McGovern Outstanding Teacher Award University of Texas Health Science Center-Houston. Dr. Hung is the only faculty who receives the latter award four times.
Dr. Hung is a basic scientist with a keen translational vision and especially his recent research effort has significantly contributed to understanding the biology of cancer and to developing combinational cancer therapies to overcome resistance. His laboratory has a long term commitment to the following research areas: His laboratory has a long term commitment to the following research areas: 1) Unravel non-canonical signal pathways of Epidermal Growth Factor Receptor (EGFR); 2) Identification of crosstalk signaling pathways in cancer cells to predict resistance for targeted therapy; 3) Elucidation of posttranslational modifications that play critical roles in tumor progression; 4) Discovery of signaling pathways and key regulators that are specific and critical to cancer stem cells proliferation; 5) Development of effectively immunotherapy and study of resistant mechanisms of immunotherapy.
Position and selected service to advisory boards
- President, China Medical University Taichung, Taiwan 02/18/2019-
- Professor, The University of Texas M.D. Anderson Cancer Center, TX, 09/94-02/17/19
- Department Chair, Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 3/2000−02/17/19
- Director, Center for Biological Pathways, The University of Texas MD Anderson Cancer Center, Houston, TX, 9/2008−02/17/19
- Vice President for Basic Research, The University of Texas MD Anderson Cancer Center, Houston, TX, 3/2010−02/17/19
- Ruth Legett Jones Distinguished Chair, The University of Texas MD Anderson Cancer Center, Houston, TX, 1/2003−02/17/19
- President (International), Society of Chinese Bioscientists in America, 2004−2005
- Member, Board of Directors, China Medical University and Hospital Health System, Taiwan, 2004-01/2019.
- Honorary Director, Center for Molecular Medicine, China Medical University and Hospital, Taichung, Taiwan, 9/2006−01/2019.
- Member, Review and Selection Committee in the Biopharmaceutical Science Category, Tang Prize, Taiwan, 2013-current.
- Member, Cancer Research Advisory Board, Ministry of Health and Welfare of Taiwan, April 10, 2014 to December 31, 2017.
- Overseas Member, Scientific Advisory Board*, Institute of Molecular and Cellular Biology, A*STAR, Singapore, June 1, 2014-May 31, 2018. *Co-chaired by two Nobel Laureates: Drs. Randy Schekman and Thomas Sudhof.
- Member, Scientific Advisory Board, Life Sciences Institute, Zhejiang University, Hengzhou, China, 2014- present.
- Member, Advisory Committee, University of Macau, Macau, China, July 2015
- Member, Selection Committee, Pezcoller Foundation-AACR Award, 2016
- Member, External Advisory Board, The University of Kansas Cancer Center, 2017-2019
- John P. McGovern Outstanding Teacher Award University of Texas Health Science Center-Houston (1990, 1993, 1999, 2018), the only faculty receives this award four times.
- Faculty Achievement Award in Education (1993) and in Basic Research (1998, 2017),
- Member, Pathology B Study Section (1996 – 2000) and Sub-committee C (2001-2005), NIH.
- Founding Editorial Board, Cancer Cell 2001-present;
- Editor-in-Chief, American Journal For Cancer Research 2015-2017
- Reappointed with the Highest Commendation by the Membership Committee, GSBS, 2005 & 2016 (five-year period)
- Senior Editor, Cancer Research, American Association for Cancer Research (2018-2021)
2006 Member, The University of Texas Academy of Health Science Education.
2007 Distinguished Teaching Professor, The University of Texas M. D. Anderson Cancer Center.
2010-16 Full Member, Scientific Advisory Council, Susan G Komen.
2010 Fellow, section of Biological Sciences, American Association for the Advancement of Science.
2010 Honorary President (life time), Breast Cancer Society of Taiwan
2011 Presidential Award, Society of Chinese Bioscientists in America,
2011 The University of Texas M. D. Anderson Cancer Center LeMaistre Outstanding Achievement Award.
2014 Outstanding Alumni Award, National Taiwan University, Taipei, Taiwan
2015 Simiao Sun Award for Biomedical Achievement, Dalian Medical University Cancer Center, China
2015-17 Co-Chair, 2017 AACR Annual Meeting Program Committee
2017 Lifetime Achievement Award, Society of Chinese Bioscientists in America
2017 Regents’ Outstanding Teaching Award, The University of Texas System
2017 Inaugural awardee of Breast Cancer Basic and Translational Research Outstanding Achievement Award, International Breast Cancer Stem Cell Symposium, Zhanjiang,
2018-2021 Honorary Dean, West China School of Basic Medical Sciences & Forensic Medicine of Sichuan University, Chengdu, China
2018-2019 President-elect, The University of Texas Academy of Health Science Education.
Summary of peer-reviewed publications
136 out of 535 peer-reviewed publications are published in journals which impact factor is 10 or above, of which 59 (44 CNS--Cell, Nature, Science series) serves as a corresponding (first or co-corresponding) author and 77 (56CNS) as a co-author. 100 out of 136 are published in Cell, Nature, Science series.
Life time h-index=118